Literature DB >> 8170378

[Condition of the respiratory system in workers involved in carbon black production].

R Szozda1.   

Abstract

Carbon black is a commercial product manufactured under controlled conditions. It is not considered as a carcinogenic substance. It is even assumed that it reduces considerably carcinogenesis of substances adsorbed on its surface. The aim of the study was to present the condition of the respiratory system of workers involved in the carbon black production. The study covered the group of exposed persons (n = 118) and the control group (n = 241). The results of environmental studies indicated excess of dust MAC values at work posts. It was concluded that exposure to carbon black was harmful to health of workers employed in its production, especially in the case of a long-term exposure to dust in concentrations exceeding MACs. Chronic bronchitis and ventilation disturbances occur more frequently in persons exposed, and smoking proved to be an additional pathogenic factor affecting health of this group of workers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170378

Source DB:  PubMed          Journal:  Med Pr        ISSN: 0465-5893            Impact factor:   0.760


  3 in total

1.  Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry.

Authors:  K Gardiner; M van Tongeren; M Harrington
Journal:  Occup Environ Med       Date:  2001-08       Impact factor: 4.402

Review 2.  The Toxicological Mechanisms of Environmental Soot (Black Carbon) and Carbon Black: Focus on Oxidative Stress and Inflammatory Pathways.

Authors:  Rituraj Niranjan; Ashwani Kumar Thakur
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

3.  Meta-Analysis of Cardiac Mortality in Three Cohorts of Carbon Black Production Workers.

Authors:  Peter Morfeld; Kenneth A Mundt; Linda D Dell; Tom Sorahan; Robert J McCunney
Journal:  Int J Environ Res Public Health       Date:  2016-03-09       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.